Cargando…
An Epitope-Specific LGI1-Autoantibody Enhances Neuronal Excitability by Modulating Kv1.1 Channel
Leucine-rich Glioma-Inactivated protein 1 (LGI1) is expressed in the central nervous system and its genetic loss of function is associated with epileptic disorders. Additionally, patients with LGI1-directed autoantibodies have frequent focal seizures as a key feature of their disease. LGI1 is compos...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454693/ https://www.ncbi.nlm.nih.gov/pubmed/36078121 http://dx.doi.org/10.3390/cells11172713 |
_version_ | 1784785409889271808 |
---|---|
author | Extrémet, Johanna El Far, Oussama Ankri, Norbert Irani, Sarosh R. Debanne, Dominique Russier, Michaël |
author_facet | Extrémet, Johanna El Far, Oussama Ankri, Norbert Irani, Sarosh R. Debanne, Dominique Russier, Michaël |
author_sort | Extrémet, Johanna |
collection | PubMed |
description | Leucine-rich Glioma-Inactivated protein 1 (LGI1) is expressed in the central nervous system and its genetic loss of function is associated with epileptic disorders. Additionally, patients with LGI1-directed autoantibodies have frequent focal seizures as a key feature of their disease. LGI1 is composed of a Leucine-Rich Repeat (LRR) and an Epitempin (EPTP) domain. These domains are reported to interact with different members of the transsynaptic complex formed by LGI1 at excitatory synapses, including presynaptic Kv1 potassium channels. Patient-derived recombinant monoclonal antibodies (mAbs) are ideal reagents to study whether domain-specific LGI1-autoantibodies induce epileptiform activities in neurons and their downstream mechanisms. We measured the intrinsic excitability of CA3 pyramidal neurons in organotypic cultures from rat hippocampus treated with either an LRR- or an EPTP-reactive patient-derived mAb, or with IgG from control patients. We found an increase in intrinsic excitability correlated with a reduction of the sensitivity to a selective Kv1.1-channel blocker in neurons treated with the LRR mAb, but not in neurons treated with the EPTP mAb. Our findings suggest LRR mAbs are able to modulate neuronal excitability that could account for epileptiform activity observed in patients. |
format | Online Article Text |
id | pubmed-9454693 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-94546932022-09-09 An Epitope-Specific LGI1-Autoantibody Enhances Neuronal Excitability by Modulating Kv1.1 Channel Extrémet, Johanna El Far, Oussama Ankri, Norbert Irani, Sarosh R. Debanne, Dominique Russier, Michaël Cells Article Leucine-rich Glioma-Inactivated protein 1 (LGI1) is expressed in the central nervous system and its genetic loss of function is associated with epileptic disorders. Additionally, patients with LGI1-directed autoantibodies have frequent focal seizures as a key feature of their disease. LGI1 is composed of a Leucine-Rich Repeat (LRR) and an Epitempin (EPTP) domain. These domains are reported to interact with different members of the transsynaptic complex formed by LGI1 at excitatory synapses, including presynaptic Kv1 potassium channels. Patient-derived recombinant monoclonal antibodies (mAbs) are ideal reagents to study whether domain-specific LGI1-autoantibodies induce epileptiform activities in neurons and their downstream mechanisms. We measured the intrinsic excitability of CA3 pyramidal neurons in organotypic cultures from rat hippocampus treated with either an LRR- or an EPTP-reactive patient-derived mAb, or with IgG from control patients. We found an increase in intrinsic excitability correlated with a reduction of the sensitivity to a selective Kv1.1-channel blocker in neurons treated with the LRR mAb, but not in neurons treated with the EPTP mAb. Our findings suggest LRR mAbs are able to modulate neuronal excitability that could account for epileptiform activity observed in patients. MDPI 2022-08-31 /pmc/articles/PMC9454693/ /pubmed/36078121 http://dx.doi.org/10.3390/cells11172713 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Extrémet, Johanna El Far, Oussama Ankri, Norbert Irani, Sarosh R. Debanne, Dominique Russier, Michaël An Epitope-Specific LGI1-Autoantibody Enhances Neuronal Excitability by Modulating Kv1.1 Channel |
title | An Epitope-Specific LGI1-Autoantibody Enhances Neuronal Excitability by Modulating Kv1.1 Channel |
title_full | An Epitope-Specific LGI1-Autoantibody Enhances Neuronal Excitability by Modulating Kv1.1 Channel |
title_fullStr | An Epitope-Specific LGI1-Autoantibody Enhances Neuronal Excitability by Modulating Kv1.1 Channel |
title_full_unstemmed | An Epitope-Specific LGI1-Autoantibody Enhances Neuronal Excitability by Modulating Kv1.1 Channel |
title_short | An Epitope-Specific LGI1-Autoantibody Enhances Neuronal Excitability by Modulating Kv1.1 Channel |
title_sort | epitope-specific lgi1-autoantibody enhances neuronal excitability by modulating kv1.1 channel |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454693/ https://www.ncbi.nlm.nih.gov/pubmed/36078121 http://dx.doi.org/10.3390/cells11172713 |
work_keys_str_mv | AT extremetjohanna anepitopespecificlgi1autoantibodyenhancesneuronalexcitabilitybymodulatingkv11channel AT elfaroussama anepitopespecificlgi1autoantibodyenhancesneuronalexcitabilitybymodulatingkv11channel AT ankrinorbert anepitopespecificlgi1autoantibodyenhancesneuronalexcitabilitybymodulatingkv11channel AT iranisaroshr anepitopespecificlgi1autoantibodyenhancesneuronalexcitabilitybymodulatingkv11channel AT debannedominique anepitopespecificlgi1autoantibodyenhancesneuronalexcitabilitybymodulatingkv11channel AT russiermichael anepitopespecificlgi1autoantibodyenhancesneuronalexcitabilitybymodulatingkv11channel AT extremetjohanna epitopespecificlgi1autoantibodyenhancesneuronalexcitabilitybymodulatingkv11channel AT elfaroussama epitopespecificlgi1autoantibodyenhancesneuronalexcitabilitybymodulatingkv11channel AT ankrinorbert epitopespecificlgi1autoantibodyenhancesneuronalexcitabilitybymodulatingkv11channel AT iranisaroshr epitopespecificlgi1autoantibodyenhancesneuronalexcitabilitybymodulatingkv11channel AT debannedominique epitopespecificlgi1autoantibodyenhancesneuronalexcitabilitybymodulatingkv11channel AT russiermichael epitopespecificlgi1autoantibodyenhancesneuronalexcitabilitybymodulatingkv11channel |